Investor presentation details FY26 growth, capacity and IPO plans
GML · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Galaxy Medicare's October 2026 investor presentation reports FY26 revenue of ₹400 million, up from ₹392 million, while EBITDA fell to ₹43 million and margin eased to 10.75% from 13.54% in FY24. PAT was ₹34 million and cash ₹132 million. Exports rose to ₹98 million. Management plans capacity expansion using IPO capex, backward integration, higher own-brand sales, OEM growth, government tenders and wider distribution.
Growth plans and strong cash support expansion, but lower EBITDA margin and dependence on two core products may weigh on investor sentiment.